Survey year | 1980 | 1995 | 2003 | Total | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Age (years) | <40 | 40–50 | >50 | <40 | 40–50 | >50 | <40 | 40–50 | >50 | |
Birth year (group) | 1946 (group C) | 1936 (group B) | 1924 (group A) | 1957 (group D) | 1950 (group C) | 1934 (group B) | 1972 (group E) | 1958 (group D) | 1948 (group C) | |
No. | 17 | 12 | 10 | 2a | 17 | 21 | 59 | 22 | 9 | 169 |
Total PCBs (ng/g lipid) | ||||||||||
 GM (GSD) | 185 (1.8) | 170 (1.4) | 125 (1.7) | 83 (2.3) | 128 (2.0) | 164 (1.9) | 68 (1.8)A | 110 (1.6)B | 242 (1.7)C* | 113 (2.0) |
 Range | 60–414 | 97–306 | 55–282 | 46–148 | 42–714 | 67–895 | 18–282 | 49–221 | 84–570 | 18–895 |
 Q1 | 105 | 118 | 76 | – | 72 | 95 | 43 | 68 | 191 | 66 |
 Q2 | 195 | 180 | 128 | – | 115 | 163 | 65 | 112 | 236 | 114 |
 Q3 | 311 | 220 | 175 | – | 181 | 222 | 106 | 157 | 356 | 182 |
 # | a | ns | ns | – | ns | ns | b | ns | ns |  |
CB-74 (ng/g lipid) | ||||||||||
 GM (GSD) | 18 (1.9) | 17 (2.0) | 12 (1.9) | 5.4 (2.0) | 7.4 (1.9) | 11 (2.1) | 3.0 (1.9)A | 4.8 (1.7)B | 11 (1.8)C* | 6.5 (2.5) |
 Range | 6.0–40 | 6.2–40 | 7.3–67 | 3.4–8.8 | 2.6–33 | 3.0–51 | 0.8–12 | 2.0–12 | 3.8–29 | 0.8–67 |
 Q1 | 10.7 | 8.8 | 8.1 | – | 4.4 | 6.8 | 1.9 | 2.8 | 8.1 | 3.3 |
 Q2 | 17 | 15 | 10.5 | – | 7.1 | 11 | 3.0 | 5.3 | 9.4 | 6.6 |
 Q3 | 33 | 35 | 12 | – | 12 | 18 | 5.0 | 7.6 | 19 | 12 |
 # | a | a | ns | – | b | ns | b | b | ns |  |
CB-99 (ng/g lipid) | ||||||||||
 GM (GSD) | 10.0 (1.9) | 9.2 (1.5) | 5.9 (1.6) | 4.1 (1.8) | 5.0 (2.2) | 6.0 (2.0) | 2.8 (1.8)A | 3.9 (1.8)A | 7.4 (2.1)B* | 4.7 (2.2) |
 Range | 2.9–26 | 4.7–16 | 3.6–18 | 2.7–6.1 | 1.1–35 | 1.2–29 | 0.9–13 | 0.9–9.8 | 1.8–22 | 0.90–35 |
 Q1 | 5.6 | 6.3 | 4.6 | – | 3.0 | 3.7 | 1.7 | 2.7 | 4.4 | 2.7 |
 Q2 | 10.6 | 9.2 | 4.9 | – | 4.1 | 6.2 | 2.5 | 4.4 | 7.9 | 4.7 |
 Q3 | 18 | 13 | 7.5 | – | 8.6 | 8.7 | 4.4 | 5.7 | 13 | 7.9 |
 # | a | a | ns | – | b | ns | b | b | ns |  |
CB-118 (ng/g lipid) | ||||||||||
 GM (GSD) | 26 (2.0) | 22 (1.3) | 17 (1.8) | 8.8 (1.7) | 12 (2.1) | 14 (2.1) | 5.8 (1.8)A | 8.9 (1.6)B | 17 (2.1)C* | 10.7 (2.2) |
 Range | 8.4–64 | 15–37 | 8.6–53 | 6.0–13 | 3.7–107 | 3.5–79 | 1.8–16 | 3.3–17 | 4.8–56 | 1.8–107 |
 Q1 | 13 | 16 | 10.8 | – | 8.2 | 10.2 | 3.7 | 5.8 | 10.1 | 5.8 |
 Q2 | 28 | 23 | 15 | – | 10.9 | 14 | 5.6 | 10.2 | 18 | 10.9 |
 Q3 | 52 | 28 | 23 | – | 17 | 20 | 9.1 | 13 | 31 | 16 |
 # | a | a | ns | – | b | ns | b | b | ns |  |
CB-138 (ng/g lipid) | ||||||||||
 GM (GSD) | 24 (1.9) | 23 (1.4) | 15 (1.6) | 11 (2.1) | 15 (2.1) | 19 (2.0) | 8.3 (1.8)A | 13 (1.7)B | 27 (1.8)C* | 14 (2.1) |
 Range | 7.8–84 | 13–45 | 7.5–33 | 6.3–18 | 4.6–121 | 7.2–167 | 2.3–31 | 4.0–27 | 8.9–64 | 2.3–167 |
 Q1 | 13 | 16 | 11 | – | 9.2 | 12 | 5.4 | 8.1 | 20 | 7.9 |
 Q2 | 24 | 24 | 15 | – | 13 | 18 | 7.8 | 14 | 23 | 14 |
 Q3 | 42 | 29 | 22 | – | 24 | 23 | 12 | 20 | 42 | 22 |
 # | a | a | ns | – | ab | ns | b | b | ns |  |
CB-146 (ng/g lipid) | ||||||||||
 GM (GSD) | 6.1 (1.8) | 6.0 (1.4) | 4.2 (1.7) | 3.1 (2.3) | 5.1 (2.1) | 6.6 (2.0) | 2.6 (2.0)A | 4.3 (1.7)B | 9.7 (1.8)C* | 4.2 (2.1) |
 Range | 2.2–18 | 3.3–12 | 1.8–7.3 | 1.7–5.6 | 1.7–32 | 2.5–45 | 0.5–13 | 1.5–11 | 2.8–22 | 0.5–45 |
 Q1 | 3.2 | 4.4 | 2.6 | – | 2.9 | 3.5 | 1.6 | 2.9 | 7.5 | 2.6 |
 Q2 | 6.5 | 5.9 | 4.9 | – | 4.7 | 6.3 | 2.5 | 4.4 | 9.9 | 4.5 |
 Q3 | 9.6 | 8.0 | 7.1 | – | 7.4 | 9.5 | 4.5 | 6.2 | 15 | 7.2 |
 # | a | ns | a | – | ns | ab | b | ns | b |  |
CB-153 (ng/g lipid) | ||||||||||
 GM (GSD) | 41 (1.8) | 40 (1.4) | 28 (1.6) | 21 (2.3) | 33 (2.1) | 42 (2.0) | 19 (1.9)A | 30 (1.6)B | 65 (1.7)C* | 29 (2.0) |
 Range | 15–115 | 25–81 | 11–53 | 12–39 | 11–188 | 18–295 | 4.9–85 | 12–64 | 23–152 | 4.9–295 |
 Q1 | 24 | 28 | 18 | – | 20 | 24 | 12 | 19 | 50 | 18 |
 Q2 | 40 | 41 | 29 | – | 32 | 39 | 18 | 30 | 65 | 29 |
 Q3 | 65 | 51 | 43 | – | 46 | 57 | 28 | 43 | 95 | 47 |
 # | a | ns | a | – | ns | ab | b | ns | b |  |
CB-156 (ng/g lipid) | ||||||||||
 GM (GSD) | 5.4 (2.0) | 4.7 (1.4) | 3.4 (1.6) | 2.7 (2.6) | 4.3 (2.3) | 5.2 (2.0) | 1.9 (2.0)A | 3.3 (1.7)B | 8.1 (1.8)C* | 3.3 (2.2) |
 Range | 1.9–18 | 2.6–08 | 1.5–6.6 | 1.4–5.4 | 1.7–48 | 1.7–39 | 0.3–6.8 | 1.5–7.0 | 2.7–19 | 0.3–48 |
 Q1 | 3.0 | 3.6 | 2.3 | – | 2.2 | 3.4 | 1.1 | 1.8 | 5.8 | 1.9 |
 Q2 | 5.0 | 4.9 | 3.7 | – | 3.8 | 5.0 | 1.9 | 3.6 | 8.4 | 3.6 |
 Q3 | 9.1 | 6.3 | 5.3 | – | 6.5 | 7.5 | 3.1 | 4.6 | 12 | 5.5 |
 # | a | ns | a | – | ns | ab | b | ns | b |  |
CB-163 & 164 (ng/g lipid) | ||||||||||
 GM (GSD) | 10.3 (1.9) | 10.3 (1.4) | 7.2 (1.6) | 4.9 (2.3) | 8.2 (2.2) | 10.7 (2.0) | 4.1 (2.0)A | 6.9 (1.6)B | 16 (1.7)C* | 6.9 (2.1) |
 Range | 3.4–34 | 6.6–20 | 3.0–13 | 2.7–9.0 | 2.9–60 | 4.1–92 | 0.8–17 | 3.0–15 | 5.2–31 | 0.8–92 |
 Q1 | 5.3 | 7.2 | 4.4 | – | 4.5 | 6.9 | 2.5 | 4.6 | 13 | 4.1 |
 Q2 | 10.2 | 10.8 | 7.8 | – | 7.8 | 9.2 | 4.1 | 7.0 | 16 | 7.4 |
 Q3 | 18 | 14 | 11 | – | 12 | 17 | 7.7 | 9.4 | 25 | 11 |
 # | a | ns | a | – | ns | ab | b | ns | b |  |
CB-170 (ng/g lipid) | ||||||||||
 GM (GSD) | 5.8 (1.7) | 5.0 (1.4) | 4.1 (1.7) | 3.4 (2.8) | 5.2 (2.0) | 6.3 (1.8) | 2.8 (1.9)A | 5.1 (1.5)B | 11 (1.6)C* | 4.4 (2.0) |
 Range | 1.9–11 | 2.8–10 | 1.5–6.9 | 1.6–6.9 | 2.2–22 | 2.2–23 | 0.5–12 | 2.6–10 | 4.3–22 | 0.5–23 |
 Q1 | 3.5 | 3.5 | 2.5 | – | 2.7 | 3.9 | 1.9 | 3.3 | 9.4 | 2.7 |
 Q2 | 6.0 | 5.3 | 5.1 | – | 4.8 | 6.1 | 2.9 | 5.5 | 10.6 | 4.9 |
 Q3 | 9.4 | 6.0 | 5.9 | – | 8.2 | 10.2 | 5.0 | 6.7 | 16 | 6.8 |
 # | a | ns | a | – | ns | a | b | ns | b |  |
CB-180 (ng/g lipid) | ||||||||||
 GM (GSD) | 21 (1.7) | 19 (1.5) | 16 (1.8) | 12 (2.9) | 19 (1.9) | 24 (1.8) | 11 (1.9)A | 20 (1.5)B | 46 (1.6)C* | 17 (2.0) |
 Range | 7.3–42 | 10.3–39 | 5.7–28 | 5.9–26 | 7.6–74 | 8.7–69 | 2.8–49 | 10.4–44 | 20–101 | 2.8–101 |
 Q1 | 14 | 13 | 8.6 | – | 10.2 | 16 | 7.2 | 15 | 35 | 10.6 |
 Q2 | 24 | 19 | 20 | – | 17 | 23 | 10.7 | 20 | 46 | 19 |
 Q3 | 31 | 25 | 25 | – | 31 | 42 | 20 | 28 | 59 | 26 |
 # | a | ns | a | – | ns | a | b | ns | b |  |
CB-182 & 187 (ng/g lipid) | ||||||||||
 GM (GSD) | 10.0 (1.7) | 9.6 (1.5) | 7.2 (1.7) | 5.1 (2.7) | 8.6 (1.9) | 11 (1.9) | 5.3 (2.0)A | 9.3 (1.7)B | 21 (1.9)C* | 8.0 (2.0) |
 Range | 3.7–20 | 5.4–23 | 2.8–12 | 2.5–10.3 | 2.7–39 | 4.9–42 | 0.9–32 | 3.1–27 | 6.0–58 | 0.9–58 |
 Q1 | 6.5 | 6.5 | 4.1 | – | 5.1 | 6.4 | 3.5 | 7.2 | 15 | 4.9 |
 Q2 | 10.2 | 9.6 | 9.2 | – | 8.7 | 11 | 5.2 | 8.9 | 21 | 8.7 |
 Q3 | 16 | 12 | 11 | – | 14 | 18 | 9.7 | 13 | 31 | 13 |
 # | a | ns | a | – | ns | a | b | ns | b |  |
Penta CBs (ng/g lipid) | ||||||||||
 GM (GSD) | 55 (1.9) | 50 (1.5) | 27 (1.8) | 18 (1.8) | 25 (2.1) | 32 (2.0) | 12 (1.8)A | 18 (1.6)B | 36 (2.0)C* | 22 (2.3) |
 Range | 17–122 | 26–86 | 10–47 | 12–28 | 7.4–175 | 8.8–126 | 3.6–36 | 6.3–35 | 10.4–108 | 3.6–175 |
 Q1 | 29 | 33 | 15 | – | 16 | 22 | 7.2 | 10.9 | 23 | 11 |
 Q2 | 68 | 47 | 34 | – | 23 | 35 | 11 | 19 | 38 | 23 |
 Q3 | 101 | 76 | 42 | – | 39 | 46 | 18 | 26 | 63 | 36 |
 # | a | a | ns | – | b | ns | b | b | ns |  |
Hexa CBs (ng/g lipid) | ||||||||||
 GM (GSD) | 87 (1.9) | 84 (1.4) | 58 (1.6) | 43 (2.3) | 66 (2.1) | 84 (2.0) | 36 (1.9)A | 57 (1.6)B | 127 (1.7)C* | 58 (2.0) |
 Range | 30–265 | 52–164 | 25–113 | 24–77 | 22–448 | 35–636 | 8.9–153 | 22–119 | 43–282 | 8.9–636 |
 Q1 | 48 | 58 | 38 | – | 39 | 48 | 23 | 34 | 99 | 35 |
 Q2 | 87 | 89 | 59 | – | 61 | 79 | 33 | 56 | 129 | 56 |
 Q3 | 145 | 106 | 89 | – | 93 | 109 | 54 | 83 | 192 | 92 |
 # | a | ns | a | – | ns | ab | b | ns | b |  |
Hepta CBs (ng/g lipid) | ||||||||||
 GM (GSD) | 37 (1.7) | 34 (1.5) | 35 (1.8) | 21 (2.8) | 33 (1.9) | 42 (1.8) | 19 (1.9)A | 35 (1.6)B | 78 (1.6)C* | 30 (2.0) |
 Range | 13–70 | 19–71 | 20–138 | 10–43 | 13–131 | 16–134 | 4.2–94 | 18–76 | 31–181 | 4.2–181 |
 Q1 | 24 | 23 | 23 | – | 18 | 27 | 13 | 24 | 63 | 18 |
 Q2 | 39 | 35 | 30 | – | 30 | 39 | 19 | 35 | 75 | 34 |
 Q3 | 58 | 44 | 42 | – | 53 | 70 | 35 | 45 | 106 | 45 |
 # | a | ns | a | – | ns | a | b | ns | b |  |